Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. (XERS) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $16.80, up 0.60% on the day, which values the company at $3.07B. Price as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.

Key facts

Share price
$16.80+0.60% today
Market value
$3.07B
Forward P/E
63.0×
Funk Score
62/100
200-week average
$4.57268% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Xeris Biopharma Holdings, Inc. in more detail

XERS trades at 63.0× next year's expected earnings, 8.3× sales. It sits 268% above its 200-week average of $4.57.

Over the last five fiscal years Xeris Biopharma Holdings, Inc. has compounded revenue 70.7% a year. Its Funk Score is 62 out of 100 (financial strength 3.9, profitability 4.7, growth 10.0, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Share count keeps rising; Thin interest cover.

Xeris Biopharma Holdings, Inc. (XERS): questions and answers

What is Xeris Biopharma Holdings, Inc.'s market cap?

Xeris Biopharma Holdings, Inc. is valued at $3.07B at a share price of $16.80.

Is XERS above its 200-week moving average?

Yes. XERS is 267.7% above its 200-week average of $4.57. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Xeris Biopharma Holdings, Inc. growing?

Over the last five fiscal years Xeris Biopharma Holdings, Inc.'s revenue grew 70.7% a year.

Does XERS pay a dividend?

Xeris Biopharma Holdings, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Xeris Biopharma Holdings, Inc. (XERS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/XERS

Underlying data: Yahoo Finance; company filings with the SEC.